Literature DB >> 30758634

[Evidence-based surgery of rectal cancer].

M Grade1, H Flebbe2, B M Ghadimi2.   

Abstract

Over the past four decades, the treatment algorithms for rectal cancer have fundamentally changed, which resulted in a considerable improvement of oncological outcomes. In this context, the surgical concept of total mesorectal excision and the implementation of multimodal treatment strategies represent key milestones. These improvements were complemented by a standardized histopathological work-up of the surgical specimen and the introduction of high-resolution magnetic resonance imaging (MRI) diagnostics. In addition, novel surgical techniques have been introduced, such as laparoscopic and robotic rectal resection. Other technological innovations include intraoperative pelvic neuromonitoring and fluorescence imaging. This review highlights the current evidence for selected, sometimes controversially discussed principles of surgical treatment strategies in rectal cancer.

Entities:  

Keywords:  Abdominoperineal extirpation; Minimally invasive rectal surgery; Neoadjuvant treatment; Primary surgery; Watch-and-wait strategy

Mesh:

Year:  2019        PMID: 30758634     DOI: 10.1007/s00104-019-0802-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  86 in total

1.  Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.

Authors:  Monique Maas; Regina G H Beets-Tan; Doenja M J Lambregts; Guido Lammering; Patty J Nelemans; Sanne M E Engelen; Ronald M van Dam; Rob L H Jansen; Meindert Sosef; Jeroen W A Leijtens; Karel W E Hulsewé; Jeroen Buijsen; Geerard L Beets
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

Review 2.  Organ preservation in rectal cancer: have all questions been answered?

Authors:  Corrie A M Marijnen
Journal:  Lancet Oncol       Date:  2014-12-29       Impact factor: 41.316

3.  Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors:  Fraser M Smith; Homer Wiland; Adam Mace; Rish K Pai; Matthew F Kalady
Journal:  Dis Colon Rectum       Date:  2014-03       Impact factor: 4.585

Review 4.  Rectal cancer: Neoadjuvant chemoradiotherapy.

Authors:  Claus Rödel; Ralf Hofheinz; Emmanouil Fokas
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-06-28       Impact factor: 3.043

5.  Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.

Authors:  Uday B Patel; Fiona Taylor; Lennart Blomqvist; Christopher George; Hywel Evans; Paris Tekkis; Philip Quirke; David Sebag-Montefiore; Brendan Moran; Richard Heald; Ashley Guthrie; Nicola Bees; Ian Swift; Kjell Pennert; Gina Brown
Journal:  J Clin Oncol       Date:  2011-08-29       Impact factor: 44.544

6.  The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy.

Authors:  F M Smith; K H Chang; K Sheahan; J Hyland; P R O'Connell; D C Winter
Journal:  Br J Surg       Date:  2012-02-20       Impact factor: 6.939

7.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer.

Authors:  Gisella V Salerno; Ian R Daniels; Brendan J Moran; R J Heald; Karen Thomas; Gina Brown
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

9.  Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.

Authors:  Phil Quirke; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Jean Couture; Chris O'Callaghan; Arthur Sun Myint; Eric Bessell; Lindsay C Thompson; Mahesh Parmar; Richard J Stephens; David Sebag-Montefiore
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321

10.  Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer.

Authors:  S Fujii; A Ishibe; M Ota; K Watanabe; J Watanabe; C Kunisaki; I Endo
Journal:  BJS Open       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.